Jump to ContentJump to Main Navigation

Edited by David A. Warrell, Timothy M. Cox, John D. Firth

Online access to the Oxford Textbook of Medicine in low and middle income countries is available through the World Health Organization-led HINARI Access to Research in Health programme

Latest update

The November 2012 update sees updates to over 70 chapters, focusing on Neurology and Gastroenterology. This update also incorporates a selection of 29 Case Histories taken from related titles in the Oxford Case Histories series, linked to from related chapters. Each case includes several questions followed by detailed answers and discussion to enhance diagnostic and clinical understanding.

Neurology updates include substantial updates to key chapters and new material on a wide range of topics including spinal cord injury, autonomic nervous system disorders, and inherited neurodegenerative diseases. 

Gastroenterology updates
include extensive revisions of key chapters on liver failure and acute pancreatitis and new material on a wide range of matters, ranging from the common to the rare: including surgical treatments for colonic diverticular disease, antibody tests for immune disorders, and a revised treatment algorithm for small bowel bacterial overgrowth.

Access token activation

If you have an access token, please click here to activate it.

Sign up for an individual subscription to the Oxford Textbook of Medicine.

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Contents

Pulmonary metastases

Chapter:
Pulmonary metastases
Author(s):

S.G. Spiro

DOI:
10.1093/med/9780199204854.003.181902

November 30, 2011: This chapter has been re-evaluated and remains up-to-date. No changes have been necessary.

Essentials

Malignant metastasis to the lung is common. It may present as a solitary enlarging nodule, as multiple nodules ranging enormously in size and number, or with diffuse lymphatic involvement. Diagnosis can usually be secured by percutaneous CT-guided biopsy. Surgical excision may prolong survival or result in cure in rare cases.

Malignant metastasis to the lung is common because of the lung’s rich blood supply, and may present as a solitary enlarging nodule, as multiple nodules, or with diffuse lymphatic involvement.

About 10% of all round pulmonary lesions are metastases, but some 70% of round lesions in patients with a known malignancy. Colorectal cancer is reported to be the commonest tumour of origin. Diagnosis can usually be secured by percutaneous CT-guided biopsy. In rare cases, surgical excision may prolong survival or result in cure, depending on the state of the primary tumour and the likelihood of other occult metastases.

Multiple metastases range enormously in size and number, from ‘cannon balls’—which are the commonest appearance—to multiple lesions of varying size, and then to miliary shadowing, which may be accompanied by hilar lymphadenopathy or pleural effusion. Breast, colon, renal, melanoma, and lung primaries are probably the commonest underlying tumours, but other tumours amenable to chemotherapy occur, such as testicular cancer, choriocarcinoma, and also sarcomas. Diagnosis may be achieved by cytology or histology on various samples from the pleura or lung and can occasionally be made from cytology of expectorated or induced sputum. Tumours that are suitable for chemotherapy (e.g. choriocarcinoma) or endocrine manipulation (e.g. breast) need to be recognized. Solitary or multiple Kaposi’s sarcoma is a feature of AIDS and can involve the bronchi and pleura as well as lung tissue.

Resection remains the treatment of choice and good prognostic factors include the time from treatment of the primary tumour to the development of lung metastases, the fewer the number, the absence of extrapulmonary metastases, and the longer the tumour doubling time. The most favourable group are younger patients with a good performance status, with sarcomas who present with few lesions a year or more after successful treatment of the primary disease. Survival following surgical excision is summarized in Table 18.19.2.1.

Table 18.19.2.1 5-year survival following resection of pulmonary metastases according to primary tumour type

Tumour type

5-year survival (%)

Soft tissue sarcoma

25

Osteogenic sarcoma

20–40

Colon/rectal carcinoma

8–37

Renal cell carcinoma

13–50

Breast carcinoma

14–49

Head/neck carcinoma

40–50

Melanoma

25

Further reading

Mountain CF, McMurtrey MJ, Hermes KE (1984). Surgery for pulmonary metastasis: a 20 year experience. Ann Thorac Surg, 38, 323–30.
Find This Resource

Regal AM, et al. (1985). Median sternotomy for metastatic lung lesions in 131 patients. Cancer, 55, 1334–9.
Find This Resource

Rusch VW (1995). Pulmonary metastatectomy: current indications. Chest, 107 (Suppl 6), 322–31S.
Find This Resource

Stewart JR, et al. (1992). Twenty years’ experience with pulmonary metastasectomy. Am Surg, 58, 100–3.
Find This Resource

Van Geel AN, et al. (1996). Surgical treatment of lung metastases: the European organization for Research and Treatment of Cancer—Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer, 77, 675–82.
Find This Resource